Lyra Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lyra Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Lyra Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $576K, a 51.7% decline year-over-year.
  • Lyra Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $3.86M, a 5.84% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.5M, a 332% increase from 2022.
  • Lyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.04M, a 921% increase from 2021.
  • Lyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $102K, a 24.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.5M +$3.46M +332% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $1.04M +$939K +921% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $102K +$20K +24.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $82K -$131K -61.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $213K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.